Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 2
Author(s): J.L.-S. Au
Affiliation:
Export Options
About this article
Cite this article as:
Au J.L.-S. , Meet Our Editorial Board Member, Current Cancer Drug Targets 2018; 18 (2) . https://dx.doi.org/10.2174/156800961802180115100706
DOI https://dx.doi.org/10.2174/156800961802180115100706 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
31
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Polymeric Nanomicelles of Soluplus® as a Strategy for Enhancing the Solubility, Bioavailability and Efficacy of Poorly Soluble Active Compounds
Current Nanomedicine Molecular Targets for Epigenetic Therapy of Cancer
Current Pharmaceutical Biotechnology Hepatic Diseases Related to Triglyceride Metabolism
Mini-Reviews in Medicinal Chemistry Targeting EZH2 for Cancer Therapy: Progress and Perspective
Current Protein & Peptide Science Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry Manipulating the Ability of Substituted Titanocene Derivatives to Induce Apoptosis in Castrate-Resistant Prostate Cancer Cells
Letters in Drug Design & Discovery Mycosporine-Like Amino Acids for Skin Photoprotection
Current Medicinal Chemistry Curcumin Therapeutic Modulation of the Wnt Signaling Pathway
Current Pharmaceutical Biotechnology Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases
Current Genomics Targeted Nanotechnology from Bench to Bedside
Current Cancer Drug Targets Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics
Current Medicinal Chemistry A Slit in Podocyte Death
Current Medicinal Chemistry Molecular Modeling Investigation of Folic Acid Conjugation to MDM2 Inhibitors for Enhanced Cellular Uptake and Target Binding
Current Computer-Aided Drug Design Gene Therapy for Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions
Reviews on Recent Clinical Trials Targeting Tumor-Associated Antigens to the MHC Class I Presentation Pathway
Endocrine, Metabolic & Immune Disorders - Drug Targets Creating A Standard of Care for Fertility Preservation
Current Women`s Health Reviews Integrins as A New Target for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
Current Drug Targets Hybrid Compounds as Multitarget Directed Anticancer Agents
Current Topics in Medicinal Chemistry